Dolby Laboratories, Inc. (DLB)
NYSE: DLB · Real-Time Price · USD
55.33
+0.56 (1.02%)
Nov 20, 2026, 4:00 PM EST - Market closed
Dolby Laboratories Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 |
| 1,421 | 1,349 | 1,274 | 1,300 | 1,254 | |
Revenue Growth | 5.32% | 5.92% | -2.00% | 3.67% | -2.14% |
Cost of Revenue | 186.5 | 160.13 | 140.5 | 152.57 | 141.36 |
Gross Profit | 1,234 | 1,189 | 1,133 | 1,147 | 1,112 |
Selling, General & Admin | 651.6 | 647.24 | 598.45 | 612.84 | 634.03 |
Research & Development | 262.78 | 261.79 | 263.66 | 271.52 | 261.17 |
Operating Expenses | 914.38 | 909.03 | 862.12 | 884.36 | 895.21 |
Operating Income | 319.99 | 279.97 | 271.11 | 262.81 | 217.23 |
Interest & Investment Income | 16.67 | 15.38 | 34.08 | 28.09 | 6.17 |
Earnings From Equity Investments | 17.5 | 24.1 | 14.2 | 5.1 | 5 |
Currency Exchange Gain (Loss) | 1.21 | 1.25 | 1.8 | 0.54 | -1.28 |
Other Non Operating Income (Expenses) | -2.43 | -2.34 | 4.08 | 0.58 | -1.22 |
EBT Excluding Unusual Items | 352.94 | 318.35 | 325.26 | 297.11 | 225.9 |
Merger & Restructuring Charges | -16 | -15.01 | -12.78 | -47.06 | -10.62 |
Gain (Loss) on Sale of Investments | 0.43 | 0.14 | - | - | - |
Pretax Income | 337.38 | 303.49 | 312.48 | 250.05 | 215.28 |
Income Tax Expense | 77.86 | 46.99 | 48.16 | 48.41 | 31.38 |
Earnings From Continuing Operations | 259.53 | 256.49 | 264.32 | 201.64 | 183.9 |
Minority Interest in Earnings | -1.79 | -1.47 | -2.49 | -0.99 | 0.19 |
Net Income | 257.74 | 255.02 | 261.83 | 200.66 | 184.09 |
Net Income to Common | 257.74 | 255.02 | 261.83 | 200.66 | 184.09 |
Net Income Growth | 1.07% | -2.60% | 30.48% | 9.00% | -40.66% |
Shares Outstanding (Basic) | 95 | 96 | 96 | 96 | 100 |
Shares Outstanding (Diluted) | 96 | 97 | 97 | 98 | 102 |
Shares Change | -1.94% | 0.16% | -0.42% | -4.17% | -2.52% |
EPS (Basic) | 2.73 | 2.66 | 2.74 | 2.10 | 1.84 |
EPS (Diluted) | 2.70 | 2.62 | 2.69 | 2.05 | 1.81 |
EPS Growth | 3.05% | -2.60% | 31.22% | 13.26% | -39.06% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 |
Free Cash Flow | 359.91 | 435.85 | 297.25 | 336.74 | 270.65 |
Free Cash Flow Per Share | 3.77 | 4.47 | 3.05 | 3.45 | 2.65 |
Dividend Per Share | 1.470 | 1.350 | 1.230 | 1.110 | 1.020 |
Dividend Growth | 8.89% | 9.76% | 10.81% | 8.82% | 12.09% |
Gross Margin | 86.87% | 88.13% | 88.97% | 88.26% | 88.72% |
Operating Margin | 22.52% | 20.75% | 21.29% | 20.22% | 17.33% |
Profit Margin | 18.14% | 18.90% | 20.56% | 15.44% | 14.68% |
Free Cash Flow Margin | 25.33% | 32.31% | 23.34% | 25.91% | 21.59% |
EBITDA | 414.99 | 367.79 | 346.67 | 345.37 | 305.69 |
EBITDA Margin | 29.21% | 27.26% | 27.22% | 26.57% | 24.38% |
D&A For EBITDA | 95.01 | 87.83 | 75.56 | 82.56 | 88.46 |
EBIT | 319.99 | 279.97 | 271.11 | 262.81 | 217.23 |
EBIT Margin | 22.52% | 20.75% | 21.29% | 20.22% | 17.33% |
Effective Tax Rate | 23.08% | 15.48% | 15.41% | 19.36% | 14.58% |
Revenue as Reported | 1,421 | 1,349 | 1,274 | 1,300 | 1,254 |
Advertising Expenses | 50.34 | 51.02 | 57.34 | 59.82 | 51.42 |